| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |